Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MITO25: Rucaparib Combinations in Advanced Ovarian Cancer
NCT03462212Phase 2Unknown
- Sponsor
- Policlinico Gemelli
- Start
- Mar 2021
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rucaparib in ovarian cancer, primary peritoneal cancer (PPC), fallopian tube cancer (PFTC), sponsored by Policlinico Gemelli. Status: unknown.
02
Drugs
rucaparib
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)fallopian tube cancer (PFTC)
Beyond the preview
Go deeper on NCT03462212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03462212.